ANNX
insider transactionsAnnexon, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $3.5M.
Net shares · 365d
+581.9K
641.6K buy · 59.7K sell
Net value · 365d
$3.2M
$3.5M in · $313.4K out
Sentiment · 365d
Net buying
92% buying · 8% selling
Open-market trades · 365d
15
641.6K buy · 59.7K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
65.0K sh
Own New
-
Grant·A
Director
$0
65.0K sh
Own New
-
Exercise·M
EVP & CHIEF INNOVATION OFFICER · 10b5-1
$0
30.6K sh
Own New
-
Exercise·M
EVP & CHIEF INNOVATION OFFICER · 10b5-1
$56.7K
30.6K sh · $1.85
Own +20%
-
Grant·A
Director
$0
65.0K sh
Own New
-
Grant·A
Director
$0
65.0K sh
Own New
-
Grant·A
Director
$0
65.0K sh
Own New
-
Grant·A
Director
$0
65.0K sh
Own New
-
Buy·P
Director
$3.3M
613.5K sh · $5.41
Own +6%
-
Buy·P
Director · 10b5-1
$46.2K
8.0K sh · $5.78
Own +11%
-
Buy·P
Director · 10b5-1
$49.6K
8.0K sh · $6.20
Own +13%
-
Buy·P
Director · 10b5-1
$45.4K
8.0K sh · $5.67
Own +15%
-
Sell·S
EVP & CHIEF INNOVATION OFFICER
$30.2K
5.6K sh · $5.42
Own -3%
-
Sell·S
EVP & CHIEF BUSINESS OFFICER
$23.5K
4.3K sh · $5.42
Own -2%
-
Sell·S
CHIEF MEDICAL OFFICER
$31.6K
5.8K sh · $5.43
Own -4%
-
Sell·S
Jennifer Lew KEY
EVP & CHIEF FINANCIAL OFFICER
$30.2K
5.6K sh · $5.42
Own -3%
-
Sell·S
EVP & CHIEF SCIENTIFIC OFFICER
$32.0K
5.9K sh · $5.43
Own -3%
-
Grant·A
EVP & CHIEF INNOVATION OFFICER
$0
250.0K sh
Own New
-
Grant·A
EVP & CHIEF INNOVATION OFFICER
$0
62.5K sh
Own +64%
-
Grant·A
EVP & CHIEF BUSINESS OFFICER
$0
250.0K sh
Own New
-
Grant·A
EVP & CHIEF BUSINESS OFFICER
$0
62.5K sh
Own +50%
-
Grant·A
Douglas Love KEY
PRESIDENT AND CEO
$0
1.2M sh
Own New
-
Grant·A
CHIEF MEDICAL OFFICER
$0
225.0K sh
Own New
-
Grant·A
CHIEF MEDICAL OFFICER
$0
56.2K sh
Own +77%
-
Grant·A
Jennifer Lew KEY
EVP & CHIEF FINANCIAL OFFICER
$0
250.0K sh
Own New
-
Grant·A
Jennifer Lew KEY
EVP & CHIEF FINANCIAL OFFICER
$0
62.5K sh
Own +55%
-
Grant·A
EVP & CHIEF SCIENTIFIC OFFICER
$0
250.0K sh
Own New
-
Grant·A
EVP & CHIEF SCIENTIFIC OFFICER
$0
62.5K sh
Own +51%
-
Sell·S
EVP & CHIEF INNOVATION OFFICER
$40.1K
7.9K sh · $5.11
Own -7%
-
Sell·S
EVP & CHIEF BUSINESS OFFICER
$31.7K
6.2K sh · $5.10
Own -5%
-
Sell·S
CHIEF MEDICAL OFFICER
$27.0K
5.3K sh · $5.10
Own -7%
-
Sell·S
Jennifer Lew KEY
EVP & CHIEF FINANCIAL OFFICER
$40.1K
7.9K sh · $5.11
Own -6%
-
Sell·S
EVP & CHIEF SCIENTIFIC OFFICER
$27.0K
5.3K sh · $5.10
Own -4%
-
Buy·P
Director · 10b5-1
$20.7K
4.1K sh · $5.02
Own +8%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Bettina M. Cockroft | Grant A | 65.0K | $0 |
| Jun 11, 2026 | William H. Carson | Grant A | 65.0K | $0 |
| Jun 11, 2026 | Ted Yednock 10b5-1 | Exercise M | 30.6K | $0 |
| Jun 11, 2026 | Ted Yednock 10b5-1 | Exercise M | 30.6K | $56.7K |
| Jun 11, 2026 | Jung Choi | Grant A | 65.0K | $0 |
| Jun 11, 2026 | William D. Waddill | Grant A | 65.0K | $0 |
| Jun 11, 2026 | William A Jones JR | Grant A | 65.0K | $0 |
| Jun 11, 2026 | Muneer A Satter | Grant A | 65.0K | $0 |
| May 28, 2026 | Muneer A Satter | Buy P | 613.5K | $3.3M |
| May 11, 2026 | William H. Carson 10b5-1 | Buy P | 8.0K | $46.2K |
| Apr 10, 2026 | William H. Carson 10b5-1 | Buy P | 8.0K | $49.6K |
| Mar 10, 2026 | William H. Carson 10b5-1 | Buy P | 8.0K | $45.4K |
| Mar 2, 2026 | Ted Yednock | Sell S | 5.6K | $30.2K |
| Mar 2, 2026 | Michael Overdorf | Sell S | 4.3K | $23.5K |
| Mar 2, 2026 | Jamie Dananberg | Sell S | 5.8K | $31.6K |
| Mar 2, 2026 | Jennifer Lew KEY | Sell S | 5.6K | $30.2K |
| Mar 2, 2026 | Dean Richard Artis | Sell S | 5.9K | $32.0K |
| Feb 19, 2026 | Ted Yednock | Grant A | 250.0K | $0 |
| Feb 19, 2026 | Ted Yednock | Grant A | 62.5K | $0 |
| Feb 19, 2026 | Michael Overdorf | Grant A | 250.0K | $0 |
| Feb 19, 2026 | Michael Overdorf | Grant A | 62.5K | $0 |
| Feb 19, 2026 | Douglas Love KEY | Grant A | 1.2M | $0 |
| Feb 19, 2026 | Jamie Dananberg | Grant A | 225.0K | $0 |
| Feb 19, 2026 | Jamie Dananberg | Grant A | 56.2K | $0 |
| Feb 19, 2026 | Jennifer Lew KEY | Grant A | 250.0K | $0 |
| Feb 19, 2026 | Jennifer Lew KEY | Grant A | 62.5K | $0 |
| Feb 19, 2026 | Dean Richard Artis | Grant A | 250.0K | $0 |
| Feb 19, 2026 | Dean Richard Artis | Grant A | 62.5K | $0 |
| Feb 18, 2026 | Ted Yednock | Sell S | 7.9K | $40.1K |
| Feb 18, 2026 | Michael Overdorf | Sell S | 6.2K | $31.7K |
| Feb 18, 2026 | Jamie Dananberg | Sell S | 5.3K | $27.0K |
| Feb 18, 2026 | Jennifer Lew KEY | Sell S | 7.9K | $40.1K |
| Feb 18, 2026 | Dean Richard Artis | Sell S | 5.3K | $27.0K |
| Dec 30, 2025 | William H. Carson 10b5-1 | Buy P | 4.1K | $20.7K |
About ANNX insider trading
This page tracks insider transactions for Annexon, Inc. (ANNX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.